In this interview, Clyde Yancy MD, MSc, FACC, and Alison L. Bailey MD, FACC, discuss the Top Takeaways from 2023 in Heart Failure. Dr. Yancy discusses trials including STEP-HFpEF, SELCT and DELIVER.

Related References:

1. Kittleson, M., Panjrath, G., Amancherla, K., Davis, L. L., Deswal, A., Dixon, D. L., Januzzi, J. L., & Yancy, C. W. (2023). 2023 ACC Expert Consensus Decision Pathway on Management of Heart Failure with Preserved Ejection Fraction. Journal of the American College of Cardiology, 81(18), 1835–1878. https://doi.org/10.1016/j.jacc.2023.03.393
2. Peikert, A., Bart, B. A., Vaduganathan, M., Claggett, B., Kulac, I. J., Kosiborod, M., Desai, A. S., Jhund, P. S., Lam, C. S., Inzucchi, S. E., Martínez, F. A., De Boer, R. A., Hernandez, A. F., Shah, S. J., Petersson, M., Langkilde, A. M., McMurray, J. J., Solomon, S. D., & Vardeny, O. (2023). Contemporary Use and Implications of Beta-blockers in Patients with HFmrEF or HFpEF: the DELIVER Trial. JACC: Heart Failure. https://doi.org/10.1016/j.jchf.2023.09.007
3. Butler J, Usman MS, Filippatos G, et al. Safety and Efficacy of Empagliflozin and Diuretic Use in Patients with Heart Failure and Preserved Ejection Fraction: A Post Hoc Analysis of the EMPEROR-Preserved Trial. JAMA Cardiol. 2023;8(7):640–649. doi:10.1001/jamacardio.2023.1090
4. Solomon, S. D., Vaduganathan, M., Claggett, B., De Boer, R. A., DeMets, D. L., Hernandez, A. F., Inzucchi, S. E., Kosiborod, M., Lam, C. S., Martínez, F. A., Shah, S. J., Bělohlávek, J., Chiang, C., Borleffs, C. J. W., Comín‐Colet, J., Dobreanu, D., Dróżdż, J., Fang, J. C., Gamba, M. a. A., . . . McMurray, J. J. (2022). Baseline characteristics of patients with HF with mildly reduced and preserved ejection fraction. JACC: Heart Failure, 10(3), 184–197. https://doi.org/10.1016/j.jchf.2021.11.006
5. McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O., Cleland, J. G., Coats, A. J., Crespo‐Leiro, M. G., Farmakis, D., Gilard, M., Heymans, S., Hoes, A. W., Jaarsma, T., Jankowska, E. A., . . . Skibelund, A. K. (2021). Corrigendum to: 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC. European Heart Journal, 42(48), 4901. https://doi.org/10.1093/eurheartj/ehab670